Nils Kroeger

5PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 01, 2025
Epidemiology, treatment patterns and effectiveness of adherence to Bacillus Calmette-Guérin therapy in intermediate and high-risk non-muscle-invasive bladder cancer patients: a retrospective cohort analysis using German health claims data.

Jaime Luna, Eveline Otte Im Kampe, Heja Aga-Barfknecht

|Dec 03, 2021
Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC.

Silvia Ribback, Stefan Winter, Tobias Klatte

|Sep 09, 2021
p53 is functionally inhibited in clear cell renal cell carcinoma (ccRCC): a mechanistic and correlative investigation into genetic and molecular characteristics.

Karoline Diesing, Silvia Ribback, Stefan Winter

|Sep 15, 2019
Evaluation of the prognostic role of co-morbidities on disease outcome in renal cell carcinoma patients.

Johannes Heide, Silvia Ribback, Tobias Klatte

|Aug 14, 2017
Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.

Jens Bedke, Johannes Heide, Silvia Ribback

Pageof 1

Frequent Collaborators

1 joint publications

Jaime Luna

1 joint publications

Eveline Otte Im Kampe

1 joint publications

Heja Aga-Barfknecht

1 joint publications

Moritz Lehne